Cancer News and Research

Latest Cancer News and Research

Etiologies of liver cancer are changing and the prognosis is mixed, study says

The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

7 Jun 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

On Tuesday, June 7, Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, will present the long-term results of a phase 2 clinical trial combining crenolanib, a second-generation FLT3 inhibitor, with standard intensive chemotherapy for treatment of adults with newly diagnosed FLT3-mutant acute myeloid leukemia (AML).

6 Jun 2022

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer.

6 Jun 2022

Phase separation discovery could lead to new interventions to regulate immune activity

Protein complexes that play a critical role in launching an immune response assemble in droplets that form within the liquid environment in cells much like oil droplets in water, UT Southwestern scientists report in a new study.

6 Jun 2022

Anesthetists play an integral role in reducing preventable maternal mortality in the UK

In a session at this year's Euroanaesthesia, Obstetric Anaesthesia Expert Dr Nuala Lucas (Northwick Park Hospital, London, UK) will examine the key messages for anesthesia practice from the UK's Maternal Mortality Reports which are produced annually to provide robust information about the causes of maternal deaths to promote learning and further reduce preventable maternal mortality in the UK and beyond.

6 Jun 2022

New fund could enable early access to life-saving treatments for NHS patients in England

NNHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks to a new fund which has been launched today.

6 Jun 2022

Color-changing mouse model aids in better visualization of internal physiology

Biomedical and genetic engineers at Duke University and the Albert Einstein College of Medicine have developed a process to change the color of a mouse's tissue in imaging to better visualize its internal physiology.

6 Jun 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Poor sleep, screen time, alcohol and tobacco use increased among Australian teens after the pandemic

Australian teens had overall improvements in sleep over the two years and some improvements in dietary choices during lockdown, however these were offset by increases in already concerning levels of screen time and worrying trends of alcohol use and poor sleep among girls.

6 Jun 2022

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Study results from three clinical trial sites show that a WW International, Inc. ("WeightWatchers" or "WW") program tailored for people living with diabetes helped participants lose weight, lower blood glucose levels, and improve their overall well-being.

6 Jun 2022

Chemo-immunotherapy combination shows promise against pancreatic cancer

A combination of chemotherapy with an immunotherapy meant to unleash the anticancer capacity of the immune system was effective against one of the hardest targets in cancer care, pancreatic cancer, in a national, randomized clinical trial led by researchers at the Perelman School of Medicine at the University of Pennsylvania, and sponsored by the Parker Institute for Cancer Immunotherapy.

6 Jun 2022

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Children (0-14 years) diagnosed with leukemia have benefited from decades of research to improve outcomes, and their five-year survival has increased more than that of adolescents (15-19 years) and young adults (20-24 years), suggests new research published in The Lancet Child and Adolescent Health.

6 Jun 2022

Electronic symptom monitoring improved quality-of-life outcomes among patients with metastatic cancer

People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community cancer clinics.

6 Jun 2022

Hospice patients with dementia more likely to receive excellent care, study shows

While the hospice program was originally designed for patients with cancer, who are expected to die within six months, currently close to half of older adult hospice enrollees have a diagnosis of dementia.

6 Jun 2022

Addition of menthol to cigarettes increases smoking frequency and nicotine dependency among youth

Currently in the public comment phase, the United States Food and Drug Administration is set to finalize rules prohibiting menthol in tobacco products, citing an effort to reduce addiction and youth experimentation, improve quitting among current smokers and address health disparities.

6 Jun 2022

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

Very few treatment options are available to patients with advanced pancreatic neuroendocrine tumors (NETs), but researchers at the Yale Cancer Center and Yale New Haven Health's Smilow Cancer Hospital found that patients treated with a combination of capecitabine and temozolomide had longer progression-free survival rates than those treated with temozolomide alone.

6 Jun 2022

New analytical method sheds light on enduring mystery about type 2 diabetes

Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't.

6 Jun 2022

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.

From Dotmatics 6 Jun 2022

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

Approximately half of children with neuroblastoma - a childhood cancer that develops from immature nerve cells - have a form that indicates a high likelihood of recurrence.

6 Jun 2022

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

A new clinical trial studying the effectiveness of a combination of immunotherapy treatments could be more effective for patients with ovarian cancer who are resistant to traditional interventions.

6 Jun 2022

Cancer News and Research

Latest Cancer News and Research

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Phase separation discovery could lead to new interventions to regulate immune activity

Anesthetists play an integral role in reducing preventable maternal mortality in the UK

New fund could enable early access to life-saving treatments for NHS patients in England

Color-changing mouse model aids in better visualization of internal physiology

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Poor sleep, screen time, alcohol and tobacco use increased among Australian teens after the pandemic

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Chemo-immunotherapy combination shows promise against pancreatic cancer

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Electronic symptom monitoring improved quality-of-life outcomes among patients with metastatic cancer

Hospice patients with dementia more likely to receive excellent care, study shows

Addition of menthol to cigarettes increases smoking frequency and nicotine dependency among youth

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

New analytical method sheds light on enduring mystery about type 2 diabetes

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in